Hypargenin C

Hypargenin C

SCHEMBL13532268

CC(C)c1cc2c(cc1O)[C@@]1(C)CCCC(C)(C)[C@@H]1C(=O)C2=O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOD1 P00441 1/20 0.55
▸ KARS1 Q15046 1/20 0.44
▸ EP300 Q09472 1/20 0.41
▸ FDPS P14324 7/20 0.38
▸ GGPS1 O95749 2/20 0.38
▸ USP2 O75604 2/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ CYP19A1 P11511 2/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ PTGES O14684 2/20 0.35
▸ PNLIP P16233 2/20 0.35
▸ BCL9 O00512 3/20 0.33
▸ CTNNB1 P35222 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hypargenin C SCHEMBL31083234 1.00 SOD1 (0.55) SOD1KARS1EP300FDPSGGPS1
Hypargenin C SCHEMBL18290364 1.00 SOD1 (0.55) SOD1KARS1EP300FDPSGGPS1
SCHEMBL18290374 0.81 FDPS (0.49) SOD1EP300FDPSGGPS1USP2
SCHEMBL13811695 0.80 EP300 (0.39) SOD1EP300USP2MEN1KMT2A
SCHEMBL15223566 0.80 EP300 (0.39) SOD1EP300USP2MEN1KMT2A
SCHEMBL18290200 0.80 SOD1 (0.76) SOD1KARS1EP300FDPSGGPS1
Sugiol SCHEMBL17407685 0.78 SOD1 (0.58) SOD1KARS1FDPSGGPS1USP2
Sugiol SCHEMBL28605319 0.78 SOD1 (0.58) SOD1KARS1FDPSGGPS1USP2
Sugiol SCHEMBL1086916 0.78 SOD1 (0.58) SOD1KARS1FDPSGGPS1USP2
SCHEMBL13532266 0.77 SOD1 (0.52) SOD1KARS1EP300FDPSGGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8519007-B2 Use certain diterpene compounds in the treatment of androgen receptor-associated diseases ACADEMIA SINICA (TW) 2013-08-27 — — US disclosed
US-8519007-B2 Use certain diterpene compounds in the treatment of androgen receptor-associated diseases ACADEMIA SINICA (TW) 2013-08-27 — — US disclosed
US-20100022632-A1 USE CERTAIN DITERPENE COMPOUNDS IN THE TREATMENT OF ANDROGEN RECEPTOR-ASSOCIATED DISEASES ACADEMIA SINICA (TW) 2010-01-28 — — US disclosed
US-20100022632-A1 USE CERTAIN DITERPENE COMPOUNDS IN THE TREATMENT OF ANDROGEN RECEPTOR-ASSOCIATED DISEASES ACADEMIA SINICA (TW) 2010-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022632-A1 USE CERTAIN DITERPENE COMPOUNDS IN THE TREATMENT OF ANDROGEN RECEPTOR-ASSOCIATED DISEASES AR, CYP17A1, CYP19A1 SOD1 4841/4885KARS1 3258/4885EP300 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback